Shoshana Shendelman - 12 Oct 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Issuer symbol
APLT
Transactions as of
12 Oct 2022
Net transactions value
+$19,943
Form type
4
Filing time
12 Oct 2022, 20:51:16 UTC
Previous filing
04 Aug 2022
Next filing
13 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Purchase $19,943 +38,153 +6.3% $0.5227 644,239 12 Oct 2022 Direct F1, F2
holding APLT Common Stock 1,750,000 12 Oct 2022 See footnote F3
holding APLT Common Stock 1,492,094 12 Oct 2022 See footnote F4
holding APLT Common Stock 709,720 12 Oct 2022 See footnote F5
holding APLT Common Stock 290,280 12 Oct 2022 See footnote F6
holding APLT Common Stock 88,397 12 Oct 2022 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased by Dr. Shendelman in multiple transactions.
F2 Weighted average price. These shares were purchased by Dr. Shendelman in multiple transactions at prices ranging from $0.504 to $0.537 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Through a grantor retained annuity trust.
F4 Through a family trust controlled by the reporting person's spouse.
F5 Through the reporting person's spouse.
F6 Through a family trust controlled by the reporting person.
F7 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.